What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
A wall street insider says SK Hynix's roughly $28 billion IPO could pull capital from AI memory stocks, triggering ra...
Oil prices have cooled, yet a veteran observer warns that upside risks could re-emerge. OPEC+ supply increases, Hormu...
Hot IPOs and rapid meme stocks grab headlines, but durable income and resilience win long games. Here are three stock...
In a volatile energy market, two durable picks stand out as no-brainer energy stocks right for many portfolios. Learn...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...
A great-looking loan deal can hide serious risks. Discover seven red flags and proven strategies to protect your mone...
Choosing between VOO and IWO boils down to what kind of U.S. stock exposure you want. This guide breaks down how the ...
As 2026 approaches, investors ask hard questions: could a stock market crash brewing scenario unfold under a Trump ad...
Investors buzz about a stock market crash coming as markets flirt with new highs. History offers both warnings and re...
Elon Musk’s trillionaire status has pushed his net worth above the non-Bitcoin crypto market cap, signaling new tensi...
Two different growth paths—mega-cap stability and nimble small-cap momentum. Learn how to balance an 'owns blue chips...